Eli Lilly

US judge overturns Eli Lilly's $176.5 million loss in Teva patent case
US judge overturns Eli Lilly's $176.5 million loss in Teva patent case
Reuters
Eli Lilly
Teva Pharmaceutical
migraines
Ajovy
Emgality
patents
legal
Flag link:
Eli Lilly receives UK approval for ulcerative colitis treatment
Eli Lilly receives UK approval for ulcerative colitis treatment
Biopharma Reporter
Eli Lilly
NICE
UK
ulcerative colitis
mirikizumab
Flag link:
FDA greenlights Jardiance for treating chronic kidney disease
FDA greenlights Jardiance for treating chronic kidney disease
Medical Marketing and Media
Eli Lilly
Boehringer Ingelheim
Medicare
Jardiance
FDA
chronic kidney disease
Flag link:
Cell therapy developer closes funding round to support diabetes program
Cell therapy developer closes funding round to support diabetes program
BioPharma Dive
cell therapy
Seraxis
funding
Eli Lilly
Flag link:
Eli Lilly sues clinics allegedly selling knockoff versions of Mounjaro diabetes drug
Eli Lilly sues clinics allegedly selling knockoff versions of Mounjaro diabetes drug
CNBC
Eli Lilly
legal
Mounjaro
diabetes
Flag link:
Novo, Lilly set to dominate $71B GLP-1 drug market by 2032: J.P. Morgan
Novo, Lilly set to dominate $71B GLP-1 drug market by 2032: J.P. Morgan
Fierce Pharma
Novo Nordisk
Eli Lilly
GLP-1 agonist
obesity
Flag link:
The Alzheimer’s Treatment Landscape: Leqembi vs. Donanemab
The Alzheimer’s Treatment Landscape: Leqembi vs. Donanemab
BioSpace
Alzheimer's disease
Eli Lilly
Biogen
Eisai
Leqembi
donanemab
Flag link:
Patent cliffs, divestitures and maturing biotechs all point to more pharma M&A: analysts
Patent cliffs, divestitures and maturing biotechs all point to more pharma M&A: analysts
Fierce Pharma
M&A
patent cliffs
Merck
JNJ
Pfizer
GSK
Novartis
Eli Lilly
Novo Nordisk
Flag link:
NICE changes its mind on Lilly's Mounjaro for diabetes
NICE changes its mind on Lilly's Mounjaro for diabetes
Pharmaphorum
Eli Lilly
Mounjaro
diabetes
NHS
UK
Flag link:
The 10 highest value R&D projects in biopharma
The 10 highest value R&D projects in biopharma
Fierce Biotech
R&D
biotech
Merck
sotatercept
Daiichi Sankyo
AstraZeneca
Dato-DXd
Novo Nordisk
CagriSema
Eli Lilly
donanemab
Karuna Therapeutics
Zai Lab
KarXT
Moderna Therapeutics
mRNA-1647
Novartis
iptacopan
Madrigal Pharmaceuticals
resmetirom
Cytokinetics
aficamten
Roche
Chugai
tiragolumab
Flag link:
Competing in These 3 Markets Could Send Eli Lilly Stock Soaring
Competing in These 3 Markets Could Send Eli Lilly Stock Soaring
Motley Fool
Eli Lilly
Alzheimer's disease
obesity
painkillers
Flag link:
Eli Lilly infiltrates anti-obesity market as Phase III trial for retatrutide begins
Eli Lilly infiltrates anti-obesity market as Phase III trial for retatrutide begins
Clinical Trials Arena
Eli Lilly
retatrutide
clinical trials
NASH
obesity
diabetes
type 2 diabetes
Flag link:
US senators push drugmakers for details on low-cost insulin programs
US senators push drugmakers for details on low-cost insulin programs
Yahoo/Reuters
Senate
insulin
drug pricing
Novo Nordisk
Eli Lilly
Sanofi
diabetes
Flag link:
With $25K donation to Pence PAC, Lilly CEO Ricks defies some of company's stated positions
With $25K donation to Pence PAC, Lilly CEO Ricks defies some of company's stated positions
Fierce Pharma
Eli Lilly
Pharma CEOs
Dave Ricks
Mike Pence
2024 Presidential election
Flag link:
Biden administration lists 10 drugs for Medicare price negotiation
Biden administration lists 10 drugs for Medicare price negotiation
Medical Marketing and Media
Medicare
HHS
Pfizer
Bristol Myers Squibb
Eli Lilly
Boehringer Ingelheim
AstraZeneca
AbbVie
Novo Nordisk
JNJ
drug pricing
Flag link:
Lilly’s Cholesterol Pill Shows Early Promise in Phase I Study
Lilly’s Cholesterol Pill Shows Early Promise in Phase I Study
BioSpace
Eli Lilly
muvalaplin
clinical trials
cholesterol
Flag link:
More US States Take on Eli Lilly in Court Over Proposed $13.5 Million Insulin Pricing Settlement
More US States Take on Eli Lilly in Court Over Proposed $13.5 Million Insulin Pricing Settlement
Xtalks
Eli Lilly
legal
insulin
Humalog
drug pricing
Arizona
Mississippi
Minnesota
Flag link:
Lilly’s Retevmo Shows Superior Survival in Phase III Thyroid Cancer Trial
Lilly’s Retevmo Shows Superior Survival in Phase III Thyroid Cancer Trial
BioSpace
Eli Lilly
Retevmo
thyroid cancer
medullary thyroid cancer
clinical trials
Exelixis
Capometyx
Sanofi
Caprelsa
Flag link:
Zacks Industry Outlook Highlights Eli Lilly, J&J, Novo Nordisk, Novartis and AstraZeneca
Zacks Industry Outlook Highlights Eli Lilly, J&J, Novo Nordisk, Novartis and AstraZeneca
Yahoo/Zacks.com
earnings
Eli Lilly
JNJ
Novo Nordisk
Novartis
AstraZeneca
Flag link:
Lilly's $13.5M insulin pricing settlement gets pushback from 9 states
Lilly's $13.5M insulin pricing settlement gets pushback from 9 states
Fierce Pharma
Eli Lilly
drug pricing
insulin
Humalog
legal
diabetes
Flag link:

Pages